
Reset all filters
01 7Abstral
02 6PecFent
03 1Pecfent
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 97
2019 Revenue in Millions : 106
Growth (%) : -9
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 40
2019 Revenue in Millions : 38
Growth (%) : 5
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 72
2020 Revenue in Millions : 97
Growth (%) : -17
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 33
2020 Revenue in Millions : 40
Growth (%) : -7
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 28
2021 Revenue in Millions : 33
Growth (%) : -15
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 52
2021 Revenue in Millions : 72
Growth (%) : -27
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 15
2022 Revenue in Millions : 28
Growth (%) : -41
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 20
2022 Revenue in Millions : 52
Growth (%) : -57
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 114
2016 Revenue in Millions : 102
Growth (%) : 12
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 39
2016 Revenue in Millions : 38
Growth (%) : 3